| ASSET | YEAR | % RETURN |
|---|---|---|
Regeneron Pharmaceuticals (REGN) | 2005 | 69.87% |
Regeneron Pharmaceuticals (REGN) | 2006 | 27.02% |
Regeneron Pharmaceuticals (REGN) | 2007 | 21.17% |
Regeneron Pharmaceuticals (REGN) | 2008 | -23.56% |
Regeneron Pharmaceuticals (REGN) | 2009 | 31.27% |
Regeneron Pharmaceuticals (REGN) | 2010 | 35.44% |
Regeneron Pharmaceuticals (REGN) | 2011 | 69.56% |
Regeneron Pharmaceuticals (REGN) | 2012 | 202.72% |
Regeneron Pharmaceuticals (REGN) | 2013 | 56.01% |
Regeneron Pharmaceuticals (REGN) | 2014 | 48.77% |
Regeneron Pharmaceuticals (REGN) | 2015 | 31.16% |
Regeneron Pharmaceuticals (REGN) | 2016 | -30.97% |
Regeneron Pharmaceuticals (REGN) | 2017 | 1.38% |
Regeneron Pharmaceuticals (REGN) | 2018 | -1.58% |
Regeneron Pharmaceuticals (REGN) | 2019 | 1.99% |
Regeneron Pharmaceuticals (REGN) | 2020 | 27.81% |
Regeneron Pharmaceuticals (REGN) | 2021 | 29.72% |
Regeneron Pharmaceuticals (REGN) | 2022 | 15.44% |
Regeneron Pharmaceuticals (REGN) | 2023 | 21.67% |
Regeneron Pharmaceuticals (REGN) | 2024 | -18.49% |
Regeneron Pharmaceuticals (REGN) | 2025 | 3.4% |
